The Emergency and Health Services Commission (EHSC) has contributed $3 million to establish Vancouver Foundation’s Emergency Medical Assistants Education Fund. The purpose of the fund is to defray license upgrade costs incurred by emergency medical assistants.
Researchers at the University of Texas Medical Branch at Galveston are trying to determine whether a drug already available to heart patients can also be used to delay delivery in expectant mothers with severe pre-eclampsia. If so, this groundbreaking study would give hope to hundreds of thousands of women who experience this life-threatening disorder each year.
Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.
A white paper that examines various state initiatives to expand access to health insurance, as well as proposals by the President and Congress in support of state efforts, was distributed today by the American College of Physicians.
Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.
Cephalon, Inc. (Nasdaq: CEPH) communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II].
VeriChip Corporation (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, responded in an effort to set the record straight in response to unbalanced press reports relating malignant tumors to the Company’s implantable microchips.
The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.
Mobile phones have not been found to be associated with any biological or adverse health effects, according to the UK”s largest investigation into the possible health risks from mobile telephone technology.
Dr. Bill Clemmer, a missionary based in the Democratic Republic of the Congo, is working with international agencies in an effort to confront an outbreak of the Ebola virus in that country.